Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Obese Pregnant Women
NCT05554679Phase 4Terminated
- Sponsor
- Assiut University
- Start
- Feb 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liquid metformin (Aspargo Labs) in obesity, sponsored by Assiut University. Primary endpoint: Neonatal birth weight. Started Feb 2021; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05554679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05554679.